Related Experiment Video

Updated: Jun 18, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

[Percutaneous intervention: indications, limitations and results except acute coronary syndrome in 2009]

E Puymirat1, D Blanchard

  • 1Service de cardiologie, hôpital européen Georges-Pompidou, 15-20 rue Leblanc, Paris, France. etiennepuymirat@yahoo.fr

Annales De Cardiologie Et D'Angeiologie
|December 9, 2009
PubMed

Insights

Percutaneous coronary interventions are effective for stabilized high-risk patients, reducing angina and improving exercise capacity. Individual risk assessment is crucial for optimal treatment selection in coronary angioplasty.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Context:

  • Percutaneous coronary interventions (PCI) are commonly performed on stable patients.
  • Recent studies, including the 2007 Courage trial, have evaluated PCI efficacy in this population.
  • PCI's established benefits include reducing angina episodes and improving exercise tolerance in high-risk stable patients.

Purpose:

  • To review the indications for coronary angioplasty in stabilized patients in France in 2009.
  • To outline the limitations of these procedures.
  • To present the results of coronary angioplasties performed on stabilized patients.

Summary:

  • Coronary angioplasty is indicated for stabilized high-risk patients, offering benefits in symptom control and exercise performance.
  • Individualized patient evaluation is essential to determine risk stratification (low, intermediate, high) and guide treatment decisions.
  • The paper provides an overview of the 2009 French landscape regarding PCI in stable patients, including its indications, limitations, and outcomes.

Impact:

  • Highlights the established role of PCI in managing stable coronary artery disease.
  • Emphasizes the importance of patient-specific risk assessment for treatment selection.
  • Informs clinical practice regarding the appropriate use of coronary angioplasty in stabilized patient populations.

More Related Videos

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...